+ 0.74
+ 0.42%

Hollister Sees 4135% Revenue Spike In Q2

August 24, 2020 12:01 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Hollister Biosciences Inc. (CSE:HOLL) (OTC: HSTRFrevealed Monday a revenue spike of 4,135% over the year to $8.47 million.

The company attributed the boost to the sale of concentrates, pre-rolls, and contract manufacturing services.

During the second quarter of fiscal 2020, Hollister posted a net income of $300,000 versus a net loss of $2.1 million in the previous quarter.

"Our second quarter results are encouraging and in line with our objective to increase revenue and profitability," said the company's President Alex Somjen.

The results are driven by increased brand awareness, strategic M&A, and strategic partnerships, added Somjen.

Some of the operational highlights from this fiscal year include ramping up its plans to launch direct to consumer delivery dubbed Dreamy Delivery in the fourth quarter, and designing and building out of its fully-owned subsidiary Venom Extracts, it bought in March for CA$20 million.

In addition, Hollister also worked on developing and launching of the product concerning the company's joint venture with Tactical Relief and its subsidiary – Alpha Mind Brands Inc.

Carl Saling, the company's CEO, said he is "enormously proud of our teams in Arizona & California."

"We look forward to continuing to execute on our plans while increasing value for our shareholders," added Saling.

Courtesy photo


Cannabis Earnings News

Related Articles

Cannabis Stock Gainers And Losers From October 30, 2020

GAINERS: Golden Leaf Holdings (OTCQB: GLDFF) shares closed up 14.71% at $0.02 read more

Green Thumb Industries Sells $79M Stake To Undisclosed Investor

Green Thumb Industries (CSE: GTI) (OTCQX: GTBIF) confirmed Friday that an undisclosed institutional investor bought 5.5 million subordinated voting shares in the company for $79 million. read more

A United Nations Vote On Cannabis Recommendations Would Be Historic

The United Nations Commission on Narcotic Drugs (CND) is slated to vote on cannabis recommendations from the World Health Organization (WHO) on Dec. 2. read more

Harvest Health Opens 8th Pennsylvania Store In King of Prussia

Vertically integrated cannabis company Harvest Health & Recreation Inc. (CSE: HARV) (OTCQX: HRVSF) is cutting the ribbon on its eight store in Pennsylvania. read more

IntelGenx And Heritage Cannabis Holdings Partner To Produce CBD Filmstrip Products

IntelGenx Corp. (TSXV: IGX) (OTCQB: IGXT) has partnered with Canadian medical cannabis producer Heritage Cannabis Holdings Corp. to produce filmstrip products containing CBD. read more